1. Home
  2. ILMN vs LII Comparison

ILMN vs LII Comparison

Compare ILMN & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$116.78

Market Cap

20.4B

Sector

Health Care

ML Signal

N/A

Logo Lennox International Inc.

LII

Lennox International Inc.

N/A

Current Price

$483.76

Market Cap

19.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ILMN
LII
Founded
1998
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
20.4B
19.5B
IPO Year
2000
1999

Fundamental Metrics

Financial Performance
Metric
ILMN
LII
Price
$116.78
$483.76
Analyst Decision
Hold
Hold
Analyst Count
17
13
Target Price
$124.24
$596.75
AVG Volume (30 Days)
1.9M
426.3K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
1.02%
EPS Growth
170.87
1.11
EPS
5.45
22.79
Revenue
$4,343,000,000.00
$5,195,300,000.00
Revenue This Year
$6.52
$6.90
Revenue Next Year
$5.49
$5.69
P/E Ratio
$22.26
$22.30
Revenue Growth
N/A
N/A
52 Week Low
$68.70
$443.19
52 Week High
$155.53
$689.44

Technical Indicators

Market Signals
Indicator
ILMN
LII
Relative Strength Index (RSI) 34.71 32.62
Support Level $114.88 $481.66
Resistance Level $135.68 $573.78
Average True Range (ATR) 4.50 18.56
MACD -0.21 -8.59
Stochastic Oscillator 1.62 2.00

Price Performance

Historical Comparison
ILMN
LII

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About LII Lennox International Inc.

Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.

Share on Social Networks: